Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)
A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
Sponsor: Mallinckrodt
Terminated
As recommended by the study's independent Data and Safety Monitoring Board (DSMB)
Other terminated trials from Mallinckrodt
Other Amyotrophic Lateral Sclerosis trials with similar outcome
This PHASE2/PHASE3 trial investigates Amyotrophic Lateral Sclerosis and is currently terminated or withdrawn. Mallinckrodt leads this study, which shows 21 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
21 versions recorded-
Nov 2025 — Present [monthly]
Terminated PHASE2/PHASE3
-
Sep 2025 — Nov 2025 [monthly]
Terminated PHASE2/PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2_PHASE3
▶ Show 16 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE2_PHASE3
-
Oct 2020 — Nov 2020 [monthly]
Terminated PHASE2_PHASE3
-
Nov 2019 — Oct 2020 [monthly]
Terminated PHASE2_PHASE3
Status: Active Not Recruiting → Terminated
-
Aug 2019 — Nov 2019 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Recruiting → Active Not Recruiting
-
Jul 2019 — Aug 2019 [monthly]
Recruiting PHASE2_PHASE3
Phase: PHASE2 → PHASE2_PHASE3
-
Dec 2018 — Jul 2019 [monthly]
Recruiting PHASE2
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE2
-
Sep 2018 — Nov 2018 [monthly]
Recruiting PHASE2
-
Jul 2018 — Sep 2018 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2
-
Apr 2018 — Jun 2018 [monthly]
Recruiting PHASE2
-
Oct 2017 — Apr 2018 [monthly]
Recruiting PHASE2
-
Sep 2017 — Oct 2017 [monthly]
Recruiting PHASE2
-
Aug 2017 — Sep 2017 [monthly]
Recruiting PHASE2
-
Jul 2017 — Aug 2017 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Mar 2017 — Jul 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Mallinckrodt
For direct contact, visit the study record on ClinicalTrials.gov .